Leerink Partners Initiates Coverage On Progyny with Outperform Rating, Announces Price Target of $49
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners analyst Michael Cherny initiates coverage on Progyny (NASDAQ:PGNY) with an Outperform rating and a price target of $49.

February 26, 2024 | 2:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Leerink Partners initiated coverage on Progyny with an Outperform rating and set a price target of $49.
The initiation of coverage by Leerink Partners with an Outperform rating and a price target significantly above the current trading price is likely to be viewed positively by investors. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100